These results suggest that ganglioside reduction as a consequence of GCS inhibition may also protect neuronal IR levels and viability upon Aβ-stress in an Alzheimer’s disease mouse model in vivo. The gene discussed is UGCG; the disease is early-onset autosomal dominant Alzheimer disease.